Condition: NSCLC Stage IIIB · NSCLC Stage IV · Sponsor: Goethe University
PACE is a prospective multicenter single-arm investigator-initiated phase II trial that examines the value of a treatment escalation strategy by the addition of platinum-based doublet chemotherapy to osimertinib in patients with treatment-naïve NSCLC harboring L858R or del19 EGFR mutation who are suspected to have poor response upon single-agent TKI treatment.
This description comes directly from the study's public registry record.
Martin Sebastian, MD · +49(0)69 6301 · martin.sebastian@kgu.de
Jan Stratmann, MD · +49(0)69 6301 · jan.stratmann@kgu.de
Always discuss trial participation with your own doctor first.
| Charité Universitätsmedizin Berlin Campus Virchow Klinikum Klinik mit Schwerpunkt Infektiologie und Pneumologie | Berlin, Germany | Recruiting |
| Universitätsklinik Köln, Lung Cancer Group Cologne - Innere Medizin I | Cologne, Germany | Recruiting |
| Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus Medizinische Klinik und Poliklinik I | Dresden, Germany | Recruiting |
| Universitätsklinikum Essen, Westdeutsches Tumorzentrum - Innere Klinik | Essen, Germany | Recruiting |
| University Hospital Frankfurt | Frankfurt, Germany | Recruiting |
| Asklepios Lungenklinik Gauting | Gauting, Germany | Recruiting |
| MVZ II der Niels Stensen Kliniken; Franziskus Hospital Harderberg | Georgsmarienhütte, Germany | Recruiting |
| Universitätsmedizin Göttingen, Klinik für Hämatologie und Medizinische Onkologie | Göttingen, Germany | Recruiting |
| Krankenhaus Martha-Maria Halle-Dölau Klinik für Innere Medizin II | Halle, Germany | Recruiting |
| Universitätsklinikum Hamburg-Eppendorf Hubertus Wald Tumorzentrum - UCCH II. Medizinische Klinik und Poliklinik | Hamburg, Germany | Recruiting |
| Universitätsklinikum Heidelberg, Thoraxklinik Heidelberg gGmbH | Heidelberg, Germany | Recruiting |
| DGD Lungenklinik Hemer | Hemer, Germany | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05281406